Trial intelligence / Profile preview

Propranolol for Prolonged Labor

NCT04741698Phase 1Completed

Sponsor
ChristianaCare
Start
Jul 2021
Primary completion
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of propranolol in labor dystocia (2 arms), sponsored by ChristianaCare. Primary endpoint: Time to delivery up to 72 hours. Started Jul 2021; status: completed.

02

Drugs

propranolol
03

Conditions

labor dystocia

Beyond the preview

Go deeper on NCT04741698.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04741698.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call